Navigation Links
Cellular Dynamics International Appoints Leroy Hood, M.D., Ph.D., and George Church, Ph.D., to its Scientific Advisory Board
Date:8/12/2009

MADISON, Wis., Aug. 12 /PRNewswire/ -- Cellular Dynamics International (CDI) announced today the appointment of Leroy Hood, M.D., Ph.D., and George Church, Ph.D., two of the world's leading scientists in molecular biotechnology and genomics, to the company's scientific advisory board. Hood and Church join stem cell pioneer James Thomson, V.M.D., Ph.D., to advise the company on strategic plans for developing induced pluripotent stem (iPS) cells into drug discovery tools and, eventually, personalized therapeutics.

"Stem cells have the potential to transform 21st century medicine -- perhaps in a manner similar to antibiotics in the 20th century," commented Dr. Hood. "I am excited about the pioneering work of Cellular Dynamics in the production of iPS cells from individual human patients and the expansion of these stems cells into tissues relevant to the study of the individual's disease."

"The commercial opportunity associated with human iPS cells is rapidly becoming complementary and/or competitive with existing markets for small molecule drugs, cord blood banking, embryonic cell research, regulatory genomic predictions, personalized toxicity and efficacy testing, and so on," said Dr. Church. "Significant demand for these cells already exists, and I am impressed with the scale, quality assurance and level of industrialization CDI has achieved and their plans to meet future demand."

"George Church and Lee Hood are thought leaders with broad experience in bringing discoveries out of their academic labs into the world where those discoveries can make a real impact on people's lives. Both have been key players in the genomic revolution, and we will look to them for creative insights into the impact of iPS cells in personalized medicine. It is an honor that they have chosen to work with us, and I am looking forward to interacting with them at our SAB meetings," said Dr. James Thomson, CDI Chief Scientific Officer. Thomson also serves as director of Regenerative Biology at the Morgridge Institute for Research and professor of anatomy at the University of Wisconsin - Madison.

"We are excited to welcome Dr. Hood and Dr. Church to CDI's Scientific Advisory Board. Lee and George are recognized as leading pioneers in the rapidly growing field of personalized medicine. Coupling their expertise with Dr. Thomson's provides an added level of scientific vision that will advance the company's goals in the development and delivery of iPS cell-based drug discovery tools and personalized medicine therapies," said Bob Palay, CEO and Chairman of CDI.

Dr. Leroy Hood is co-founder and president of the Institute for Systems Biology, Seattle. He pioneered a multi-disciplinary approach to better understand the complexity of biological systems and medicine. He holds 15 patents in the biomedical field, including for the DNA sequencer, which revolutionized automated DNA sequencing and played a critical role in the mapping carried out in the Human Genome Project. Dr. Hood has won several major awards for his contributions in medicine and biotechnology, including the 2008 Pittcon Heritage Award; 2007 election to the Inventors Hall of Fame for the automated DNA sequencer; the 2006 Heinz Award for Technology, the Economy and Employment; the 2004 Biotechnology Heritage Award; the 2003 Association for Molecular Pathology (AMP) Award for Excellence in Molecular Diagnostics; the 2003 Lemelson-MIT Prize for Innovation and Invention; and the 2002 Kyoto Prize in Advanced Technology. He has played a role in founding more than 14 biotechnology companies, including Amgen and Applied Biosystems.

Dr. George Church is professor of genetics at Harvard Medical School; director of the Lipper Center for Computational Genetics, DOE Genomes to Life Center, NIH Center for Excellence in Genomic Science, and the Personal Genome Project; as well as member of the Wyss Institute and Broad Institute. He pioneered the first direct genomic sequencing method, which led to the first commercial genome sequence, and to second-generation sequencing -- e.g. open-source Polonator.org. Dr. Church has 34 patents including molecular multiplexing and tags, homologous recombination methods, and DNA array synthesizers. He has advised 24 companies, including founding LS9, JouleBio, and Knome.

About Cellular Dynamics International, Inc.

Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development and personalized medicine applications. CDI harnesses the power of pluripotent stem cells and their ability to differentiate into any cell type for world-class drug development tools. In addition, it is the leader in iPS technology, the production of pluripotent stem cell lines from adult tissue. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human embryonic stem cell research at the University of Wisconsin-Madison, and Tactics II Ventures, a Wisconsin-based venture capital fund. CDI's facilities are located in Madison, Wisconsin.

See www.cellulardynamics.com.


'/>"/>
SOURCE Cellular Dynamics International (CDI)
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International
2. Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing
3. Cellular Dynamics International Reprograms Blood Cells into Stem Cells
4. iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
5. Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
6. New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the Worlds Leading Bioenergetics Researchers
7. MIT, BU engineer cellular circuits that count events
8. Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
9. Orange and Medic4all Launched the Worlds First Cellular Tele-Health Service
10. MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting
11. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... SAN DIEGO and BEIJING ... Ltd., a leading commercial provider of genomic services and ... expertise, announced today that it has completed a USD ... China Merchants Bank Co., Ltd.,s CMB International Capital Management ... SDIC Innovation Investment Management Co., Ltd. ("SDIC Innovation") and ...
(Date:11/30/2016)... Mass. , Nov. 30, 2016   Merck ... that it has entered into a set of agreements ... services for Merck,s collection of genetic reagents such as ... with Evotec,s screening expertise offers an accelerated pathway to ... discovery starts with the identification of new targets, a ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... development of a new orally administered treatment for Alzheimer’s disease (AD), today announced ... a Phase 2a clinical trial of T3D-959 in mild to moderate Alzheimer’s patients ...
(Date:11/30/2016)... ... November 30, 2016 , ... ProMIS Neurosciences (“ProMIS” or the ... diseases, today announced that all five of its validated monoclonal antibody (mAb) therapeutic ... toxic, prion-like forms of Amyloid beta (Aß) in vitro. , “We previously demonstrated ...
Breaking Biology Technology:
(Date:6/20/2016)... -- Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring announced that after exhaustive ... the final acceptance by all three (3) Department ... (MAS) installed. Furthermore, Securus will have contracts for ... October, 2016. MAS distinguishes between legitimate wireless device ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):